MATINAS BIOPHARMA HOLDINGS, INC. Finance Lease, Right-of-Use Asset, Amortization
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Finance Lease, Right-of-Use Asset, Amortization of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $1.00K, a 0.00% change year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $1.00K, a 0.00% change year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $1.00K, a 0.00% change year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $1.00K, a 50.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $4.00K, a 20.00% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $5.00K, a 37.50% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $8.00K, a 57.89% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $19.00K, a 47.22% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-13 | $1.00K 10-Q · filed 2026-08-13 | ||||||
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.00K derived: sum of 3 quarters · filed 2026-08-13 | $4.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-10 | $2.00K derived: sum of 2 quarters · filed 2026-08-13 | $3.00K 10-Q · filed 2025-11-10 | $4.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-13 | $2.00K 10-Q · filed 2026-08-13 | $3.00K derived: sum of 3 quarters · filed 2026-08-13 | $4.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-08 | $2.00K derived: sum of 2 quarters · filed 2026-05-08 | $3.00K derived: sum of 3 quarters · filed 2026-05-08 | $5.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.00K derived: sum of 2 quarters · filed 2026-03-31 | $4.00K derived: sum of 3 quarters · filed 2026-03-31 | $5.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-10 | $3.00K derived: sum of 2 quarters · filed 2025-11-10 | $4.00K 10-Q · filed 2025-11-10 | $5.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-14 | $3.00K 10-Q · filed 2025-08-14 | $4.00K derived: sum of 3 quarters · filed 2025-08-14 | $6.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-15 | $2.00K derived: sum of 2 quarters · filed 2025-05-15 | $4.00K derived: sum of 3 quarters · filed 2025-05-15 | $5.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $3.00K derived: sum of 2 quarters · filed 2025-04-15 | $4.00K derived: sum of 3 quarters · filed 2025-04-15 | $8.00K 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-13 | $3.00K derived: sum of 2 quarters · filed 2024-11-13 | $7.00K 10-Q · filed 2024-11-13 | $11.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-14 | $5.00K 10-Q · filed 2024-08-14 | $9.00K derived: sum of 3 quarters · filed 2024-08-14 | $12.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-09 | $8.00K derived: sum of 2 quarters · filed 2024-05-09 | $11.00K derived: sum of 3 quarters · filed 2024-05-09 | $17.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $7.00K derived: sum of 2 quarters · filed 2024-03-27 | $13.00K derived: sum of 3 quarters · filed 2024-03-27 | $19.00K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $3.00K 10-Q · filed 2023-11-08 | $9.00K derived: sum of 2 quarters · filed 2023-11-08 | $15.00K 10-Q · filed 2023-11-08 | $15.24K 10-Q · filed 2022-11-02 | $21.70K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $6.00K 10-Q · filed 2023-08-09 | $12.00K 10-Q · filed 2023-08-09 | $11.85K 10-Q · filed 2022-08-11 | $18.70K derived: sum of 3 quarters · filed 2023-08-09 | $27.70K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $6.00K 10-Q · filed 2023-05-10 | $6.43K 10-Q · filed 2022-05-12 | $12.70K derived: sum of 2 quarters · filed 2023-05-10 | $21.70K derived: sum of 3 quarters · filed 2023-05-10 | $30.70K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $6.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $15.70K derived: sum of 2 quarters · filed 2023-03-15 | $24.70K derived: sum of 3 quarters · filed 2023-03-15 | $36.00K 10-K · filed 2023-03-15 | $35.74K 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-02 | $18.00K derived: sum of 2 quarters · filed 2022-11-02 | $29.30K 10-Q · filed 2022-11-02 | $38.66K derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-11 | $20.66K 10-Q · filed 2022-08-11 | $29.66K derived: sum of 3 quarters · filed 2022-08-11 | $38.66K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $12.01K 10-Q · filed 2022-05-12 | $20.66K derived: sum of 2 quarters · filed 2022-05-12 | $29.66K derived: sum of 3 quarters · filed 2022-05-12 | $48.66K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $8.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $17.64K derived: sum of 2 quarters · filed 2022-03-11 | $36.64K derived: sum of 3 quarters · filed 2022-03-11 | $58.96K 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-08 | $8.60K 10-Q · filed 2020-11-06 | $28.00K derived: sum of 2 quarters · filed 2021-11-08 | $50.32K 10-Q · filed 2021-11-08 | $75.93K derived: sum of 4 quarters · filed 2021-11-08 | |||
| 2020-06-30 | $19.00K 10-Q · filed 2021-08-10 | $18.80K 10-Q · filed 2020-08-10 | $41.68K 10-Q · filed 2021-08-10 | $66.93K derived: sum of 3 quarters · filed 2021-08-10 | $91.93K derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $22.92K 10-Q · filed 2021-05-10 | $47.93K derived: sum of 2 quarters · filed 2021-05-10 | $72.93K derived: sum of 3 quarters · filed 2021-05-10 | $109.33K derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $50.00K derived: sum of 2 quarters · filed 2021-03-29 | $86.40K derived: sum of 3 quarters · filed 2021-03-29 | $122.80K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $25.00K 10-Q · filed 2020-11-06 | $61.40K derived: sum of 2 quarters · filed 2020-11-06 | $97.79K 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $36.40K 10-Q · filed 2020-08-10 | $36.00K 10-Q · filed 2019-08-13 | $72.79K 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | $36.40K 10-Q · filed 2020-05-11 | |||||||
| 2018-06-30 | $5.00K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |